MAVENCLAD
Identification of Mavenclad
| No description |
Google image searchProduct monograph
Active ingredient
cladribine, 10 MG
DIN: 02470179
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: EMD SERONO, A DIVISION OF EMD INC., CANADA
Date: 30-NOV-2017
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AA — Selective immunosuppressants (ATC, ATC/DDD)
- L04AA40 — CLADRIBINE (ATC/DDD)
